Lebenthal Global Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Lebenthal Global Advisors's ELV Position: Q3 2026 in Review
Lebenthal Global Advisors reduced its Elevance Health (ELV) stake by 15% in Q3 2026, selling an estimated $98.2K and leaving 1,393 shares worth $542K. The position accounts for 0.07% of the portfolio, ranked #153.
Lebenthal Global Advisors first reported a position in ELV in Q4 2023 and has held it in 9 quarters since. The position peaked at $634K in Q2 2026. 1,621 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- Lebenthal Global Advisors held 1,393 shares of Elevance Health worth $542K as of Q3 2026.
- Lebenthal Global Advisors sold 246 Elevance Health shares in Q3 2026, an estimated $98.2K.
- Elevance Health made up 0.07% of Lebenthal Global Advisors's portfolio in Q3 2026, its #153 holding.
- Lebenthal Global Advisors first reported a position in Elevance Health in Q4 2023 and has held it in 9 quarters since.
- Lebenthal Global Advisors's Elevance Health position peaked at $634K in Q2 2026.
- 1,621 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on Lebenthal Global Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.